Interventions for dialysis patients with hepatitis C virus (HCV) infection

CONCLUSIONS: In dialysis patients with HCV infection grazoprevir plus elbasvir probably improves ETR. There is no difference in ETR or SVR for combinations of telaprevir, ribavirin and PEG interferon given for different durations and doses. Though no longer in use, PEG interferon was more effective than standard interferon for ETR but not SVR. Increasing doses of PEG interferon did not improve responses. The addition of ribavirin to PEG interferon may result in fewer relapses, higher SVR, and higher numbers with adverse events.PMID:37096802 | PMC:PMC10130818 | DOI:10.1002/14651858.CD007003.pub3

Source: Cochrane Database of Systematic Reviews - April 25, 2023 Category: General Medicine Authors: Attur Ravindra Prabhu Indu Ramachandra Rao Shankar Prasad Nagaraju Eti Rajwar Bhumika T Venkatesh Sreekumaran Nair N Ganesh Pai Nageswara P Reddy Deepak Suvarna Source Type: research